Building on the successful launches of its MINI micro-hyperbaric oxygen chamber and hydrogen generation machine products in this September, JinMed has recently unveiled S-type (accommodating 2-3 people) and M-type (accommodating 4-6 people) micro-hyperbaric oxygen chambers. Engineered with precision and designed for optimal therapeutic benefits, these chambers are intended to redefine standards in the healthcare industry. Conlo, recognizing the potential of these innovative products, has placed substantial orders totaling
Anticipating robust demand, Conlo plans to deploy 10,000 oxygen chambers for human and 10,000 pet oxygen chambers, all of which will be exclusively sourced from JinMed in the Chinese market over the next three years. This strategic collaboration underlines JinMed's commitment to delivering innovative healthcare solutions and meeting the evolving needs of its consumers.
Mr. Erqi Wang, the Chairman and CEO of the Company commented: "The Micro-Hyperbaric Oxygen Chamber equipment, developed by JinMed, represents a breakthrough in the field of medical technologies. Securing
Micro-hyperbaric oxygen therapy in a micro-hyperbaric oxygen chamber is known to have the characteristics of low pressure and high safety. It is suitable for the elderly, patients with chronic diseases, beauty lovers, people with compromised health conditions, athletes, obese people and postoperative rehabilitation patients. The product has the functions of daily oxygen protection, health improvement, postoperative recovery, immunity enhancement and anti-aging. Everyday use of the Micro-hyperbaric oxygen chambers will rapidly increase combination oxygen and dissolved oxygen content, blood flow speed, cellular repair, and help to improve metabolism and balance of the body. From the anti-aging aspect, long-term use of high pressure oxygen is known to enhance the cell vitality, effectively prolong grain, reduce the senescent cells, and improve skin metabolism, resulting in certain anti-aging effects.
About
Founded in 2006 and headquartered at
Forward-Looking Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the
For more information, please contact:
ir@zhjmedical.com
Source:
2023 GlobeNewswire, Inc., source